Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Acute Coronary Syndromes (ATLAS ACS-TIMI 46)
NCT00402597Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of rivaroxaban in acute coronary syndrome (ACS), sponsored by Johnson & Johnson. Started Nov 2006; status: completed.
02
Drugs
rivaroxaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00402597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402597.